SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

Midterm election results and the prospect of a Democratic sweep dominate discussion, with traders blaming perceived regulatory and AI-spending risks for QQQs sharp volatility while others argue the outcome was priced in and the selloff is an overreaction. Strong AMD and Super Micro results also fueled optimism about AI-related tech and a possible rebound.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

U.S. midterm results and forecasts of Democratic gains are driving attention, with traders debating whether a shift in congressional control could weaken Trump politically and pressure his media-linked stock. Many posts are bearish on that prospect, while others argue midterm losses are typical or that a mixed result could limit the downside.

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMDs quarterly earnings beat and stronger outlook, driven by surging AI data-center demand, sparked a sharp rally and renewed optimism about growth into 2027. Traders remain divided, with concerns about valuation, weaker cash flow and dependence on data-center spending weighing against the bullish outlook, while broader market and election worries contributed to volatile trading.

Super Micro Computer, Inc. engages in the distribution and manufacture of information technology solutions and other computer products. Its products include twin solutions, MP servers, GPU and coprocessor, MicroCloud, AMD solutions, power supplies, SuperServer, storage, motherboards, chassis, super workstations, accessories, SuperRack and server management products. The company was founded by Charles Liang, Yih-Shyan Liaw, Sara Liu, and Chiu-Chu Liu Liang in September 1993 and is headquartered in San Jose, CA.

Super Micro Computer Inc

Super Micros quarterly results and raised full-year outlook, driven by strong AI-server demand, are the main focus. Many traders call the results a major beat and see the shares as undervalued, while others question thin margins, cash flow, and lingering management credibility concerns that may be weighing on the stocks muted response.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bull 3X ETF

Direxion Daily Semiconductor Bull 3X Shares

SOXL chatter centers on sharp swings in semiconductor stocks amid concerns about an AI trade pullback, election uncertainty, and selling in chip names such as AMD, Intel, and Marvell. Traders remain divided between expecting a rebound on strong chip demand and earnings, and warning that persistent selling and leveraged-ETF decay could deepen losses.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

Midterm-election uncertainty is driving volatility in Nvidia and the broader AI trade, with traders debating whether a Democratic sweep could weigh on data-center spending and AI regulation or whether the risk is already priced in. AMDs strong results are also fueling optimism that AI-chip demand remains resilient, supporting a semiconductor rebound.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Attention centers on 28 HOPE-3 investigators letter urging FDA approval of deramiocel for non-ambulatory Duchenne muscular dystrophy, bolstering optimism ahead of the November 22 decision. Many traders see the letter as support for approval and anticipate short covering, while others point to the FDAs prior concerns and advisory-committee skepticism; claims of a leak remain speculation.

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

Nebius is drawing attention amid a sharp, sector-wide selloff in AI infrastructure and neocloud stocks, as traders debate whether the AI buildouts debt, funding needs and uncertain profitability justify lower valuations. Bulls call the decline an oversold, market-driven pullback and are buying dips, while bears warn that financing risks and bubble concerns could drive further losses; the latest bounce has not settled the debate.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Election-related concerns about Musks political ties and possible scrutiny of Tesla and SpaceX dominate the discussion, alongside speculation about a potential merger between the companies. The mood is largely bearish, though some traders view a merger as a catalyst for upside, and short-term direction remains contested.

Cipher Digital, Inc. operates as a Bitcoin mining ecosystem in the United States. The firm is developing a cryptocurrency business. The company was founded in 2021 and is headquartered in New York, NY.

Cipher Digital Inc.

Cipher Digitals sharp rebound after a steep selloff is drawing attention, with traders weighing analyst calls that the shares are undervalued and a broader AI-infrastructure recovery against the recent revenue miss and concerns about execution and financing. Some attribute the move to short covering, while others see it as a temporary bounce.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Should You Invest in the iShares U.S. Medical Devices ETF (IHI)?

BSX Stock Looks To Snap 3-Week Winning Streak: Analysts Downgrade Boston Scientific As Cyberattack And Slowing Growth Cloud Outlook

Equity

Boston Scientific’s weak outlook, cyberattack disruptions, and slowing Watchman and electrophysiology growth weighed on sentiment.


The Silver Tsunami: Healthcare ETFs to Buy Amid Aging US Demographics

 ETFs like XLV stand out as aging U.S. demographics fuel rising demand for healthcare, medical devices and senior-focused care. 

Buy the Dip in These Top-Ranked ETFs

Market volatility from Iran tensions has created dip-buying chances. Here are 5 ETFs across tech, semis, dividends, healthcare and financials.

Why Did BFLY Stock Surge More Than 23% Pre-Market Today?

The company posted Q4 revenue of $31.5 million, marking a 41% increase year-on-year (YoY), while the adjusted loss per share (EPS) for the quarter was $0.02.


Why Did GUTS Stock Plummet Today Despite Positive Gut Therapy Midterm Study? 

Six-month data from 40 participants suggest that Revita helps limit weight regain after GLP-1 discontinuation.


iShares Trust - iShares U.S. Medical Devices ETF

Neutral Sentiment

<ul class="summary-bullets"><li>Despite beating Q3 earnings estimates, Boston Scientific faces growth concerns.</li><li>Jefferies downgraded the stock to ‘Hold,’ cutting its price target to $46 from $60.</li><li>JPMorgan downgraded Boston Scientific to ‘Neutral’ and pointed to delayed product programs.&nbsp;&nbsp;&nbsp;</li></ul><p>Boston Scientific Corp. (BSX) stock is on track to reverse a&nbsp; three-week winning streak as Wall Street turns cautious after its third-quarter (Q3) results and a weaker 2026 outlook. Jefferies and JPMorgan downgraded the stock, slashing price targets over cyberattack fallout, slowing product growth and a delayed pipeline that could affect its 2027 performance.&nbsp;</p><p><a href="https://stocktwits.com/symbol/BSX">Boston Scientific stock</a> edged up 0.4% overnight, ahead of Thursday. The stock has fallen more than 7% so far this week.&nbsp;</p><h2 class="st-heading-2">Jefferies Downgrades Boston Scientific As Growth Catalysts Fade</h2><p>Though Boston Scientific’s third-quarter (Q3) earnings beat expectations, concerns about slower business momentum, delayed product development milestones and the lingering effects of a cyber incident have clouded its near-term outlook.</p><p>Jefferies analyst Matthew Taylor cut the medical device maker's stock to ‘Hold’ from ‘Buy’ and slashed his price target to $46 from $60, implying only an 8% upside from the stock’s last closing price.&nbsp;</p><p>The analyst cited uncertainty surrounding pulsed field ablation (PFA) and Watchman products, alongside a challenging business outlook and a limited number of growth drivers expected in 2027. Taylor expects the shares to remain range-bound over the coming quarters, with opportunities for growth only emerging in 2028 and later.</p><h2 class="st-heading-2">JPMorgan Flags Broader Business Concerns For&nbsp;Boston Scientific</h2><p>JPMorgan also took a cautious stance, shifting its rating to ‘Neutral’ from ‘Overweight’ and cutting its price target to $46 from $56. The analyst acknowledged that investors expected adjustments to the company's guidance after a cyber incident in Q3. However, the firm believes the weaker outlook extends beyond conservative financial projections.</p><p>The analyst said Boston Scientific expects slower sales and earnings growth in 2027. Delays in several product development projects also raised concerns about the company’s ability to meet its goals. The company cut its full-year adjusted earnings outlook to $3.16 to $3.18 per share from its prior estimate of $3.28 to $3.32 per share.&nbsp;</p><p>Needham lowered its price target to $48 from $57 but maintained a ‘Buy’ rating. While the cyber incident had already led investors to anticipate weaker guidance, Needham said other developments in the report added to the negative outlook. The disruption is now expected to affect Q4 results as well. Meanwhile, growth in the Watchman business and electrophysiology products weakened again, even after accounting for the cyber-related impact.</p><h2 class="st-heading-2">BSX Stock: Retail View&nbsp;</h2><p>However, on Stocktwits, retail sentiment around the stock flipped to ‘bullish’ from ‘bearish,’ with 1,161% surge in message volume over the past 24 hours.&nbsp;</p><p>A user&nbsp;<a href="https://stocktwits.com/St0ckt0k101/message/667612197">said</a>, “gotta watch for more price cuts!! You know they're coming to bring this down some more. Long and CANNOT sell this low.”</p><p>BSX stock has crashed 55% year-to-date.&nbsp;</p><p>Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/why-is-cvna-stock-rising-8-overnight/cZUQO5PR9be">Why Is CVNA Stock Rising 8% Overnight?</a></p><p><i>For updates and corrections, email newsroom[at]stocktwits[dot]com.</i></p>

 In this photo illustration, a smartphone displays the logo of Boston Scientific Corporation.

Boston Scientific Corp. (BSX) stock is on track to reverse a three-week winning streak as Wall Street turns cautious after its third-quarter (Q3) results and a weaker 2026 outlook. Jefferies and JPMorgan downgraded the stock, slashing price targets over c

Current Price	$56.43
Prev Close	$56.51
Open	$56.21
Dividend Yield	N/A
50-Day Moving Average	$53.04
Beta	N/A
Avg. Volume	3.23M
PE Ratio	N/A

52-Week High	$64.71
52-Week Low	$47.37
Market Capitalization	N/A
EPS (Annual)	N/A
Price to Book	N/A
Revenue Per Employee	N/A

Feed

News

Sentiment

Fundamentals

Info

IHI Fundamentals